Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to study the efficacy of endoscopic cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration in the prevention of gastric variceal bleeding.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BRTO | Active Comparator | Balloon-occluded retrograde transvenous obliteration |
|
| NBCA | Active Comparator | Endoscopic cyanoacrylate injection |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Balloon-occluded retrograde transvenous obliteration | Procedure | Balloon-occluded retrograde transvenous obliteration |
|
| Measure | Description | Time Frame |
|---|---|---|
| Bleeding rate from gastric varices | 3 years |
| Measure | Description | Time Frame |
|---|---|---|
| Eradication rate of gastric varices | 3 years | |
| Number of participants with increase or decrease in the size of gastric varices | 3 years | |
| Number of participants with appearance or worsening of new oesophageal varices |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Xufeng Luo, MD | Contact | luo_xuefeng@yeah.net |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| West China Hospital | Recruiting | Chengdu | Sichuan | 610041 | China |
Not provided
| ID | Term |
|---|---|
| D004932 | Esophageal and Gastric Varices |
| ID | Term |
|---|---|
| D004935 | Esophageal Diseases |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
| D006975 | Hypertension, Portal |
Not provided
Not provided
| ID | Term |
|---|---|
| D004659 | Enbucrilate |
| D000077423 | Polidocanol |
| ID | Term |
|---|---|
| D003487 | Cyanoacrylates |
| D000179 | Acrylates |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Endoscopic cyanoacrylate injection | Procedure | Endoscopic cyanoacrylate injection |
|
| N-butyl-2-cyanoacrylate | Drug |
|
| Lauromacrogol | Drug |
|
| 3 years |
| Number of participants with appearance or worsening of portal hypertensive gastropathy | 3 years |
| Number of participants with appearance or worsening of ascites | 3 years |
| Number of participants with complication | 3 years |
| Average in-hospital stay | 3 years |
| Cost of treatment | 3 years |
| Mortality rate | 3 years |
| D008107 | Liver Diseases |
| D009930 |
| Organic Chemicals |
| D009570 | Nitriles |
| D011108 | Polymers |
| D046911 | Macromolecular Substances |
| D001697 | Biomedical and Dental Materials |
| D014014 | Tissue Adhesives |
| D008420 | Manufactured Materials |
| D013676 | Technology, Industry, and Agriculture |
| D011092 | Polyethylene Glycols |
| D005026 | Ethylene Glycols |
| D006018 | Glycols |
| D000438 | Alcohols |